Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05324956
Other study ID # 2021/348
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 2022
Est. completion date June 2022

Study information

Verified date April 2022
Source Izmir Bakircay University
Contact Öykünur Cansu
Phone +902324930000
Email 6009121@bakircay.edu.tr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

If the bone mineral density of a patient with a diagnosis of osteopenia falls further, he develops osteoporosis.Menopause causes many changes in women's bodies in the form of vasomotor, sleep disorders, fatigue, aches and pains, altered cognitive functions, as well as genitourinary problems such as vaginal dryness, irritation, recurrent urinary tract infections. In the long term, inevitable changes occur in the musculoskeletal system. Osteoporosis, sarcopenia, postural dysfunction, regression in gait cycle, Loss of balance control and instability and increased risk of falling are the changes reported during this period. These mentioned effects negatively affect the quality of life of women. The aim of this study is to investigate the relationship of bone mineral density with respiratory functions and exercise capacity in postmenopausal women.The second aim is to compare the respiratory functions and exercise capacities of postmenopausal women with osteopenia and osteoporosis.


Description:

The 1993 Consensus Development Conference paper defined osteoporosis as ''a disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to increased bone fragility and consequent increased risk of fracture.In 1994, the World Health Organization (WHO) established criteria for measuring bone mineral density (BMD) that allowed the diagnosis of osteoporosis before fractures. This practical definition is based on the main (known) risk factor: reduced bone strength or density and people at high risk but without fractures.Premenopausal women have a low rate of osteoporosis; however, the prevalence increases with age due to progressive bone loss.Bone densitometry is an established method for evaluating osteoporosis. Various different methods have been developed in the last 25 years. DEXA is recommended and FDA approved for BMD measurement; It is precise, noninvasive, has low radiation exposure and takes 10 minutes to administer. Osteoporosis can have a significant impact on patients' daily lives. Vertebral deformity causes loss of spinal mobility, and patients with osteoporosis have difficulty standing, bending over, getting up from a chair, walking, carrying objects, dressing, fixing hair, bathing, moving in bed, using the toilet, and descending to the floor. Compared with women without existing vertebral deformities, women with extensive deformities have higher crude mortality and hospitalization rates overall.Osteoporosis deprives older women of many of their social roles. Failure to fulfill roles such as cooking, housework, work, and intimacy can be devastating, leading to frustration and embarrassment. Interpersonal relationships can be deeply affected by the effects of osteoporosis, straining family ties and destroying extra-familial relationships, leading to social isolation. Therefore, treatment options should be well evaluated because affected individuals should focus not only on bone remodeling, but also on ways in which negative outcomes such as pain, depression and loss of self-esteem can be improved. Considering all these situations, we asked the question whether there is any relationship between bone mineral density and respiratory functions and exercise capacity. In order to evaluate these parameters, we decided to examine the patient's detailed demographic information, posture evaluation according to the New York Posture Scale, 6-minute walking test result, and Pulmonary Function Test result.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 80
Est. completion date June 2022
Est. primary completion date April 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: - Between 40-80 years old - Female gender - Being diagnosed with menopause - Being diagnosed with osteoporosis or osteopenia - Volunteer to participate in the study Exclusion Criteria: - Hemoptysis of unknown cause - Recent abdominal, thoracic, or eye surgery - Thoracic, abdominal, or cerebral aneurysm - pulmonary embolism - Mental state disorder that interferes with cooperation - Arrhythmias disrupting hemodynamics - Having any diagnosed disease affecting the respiratory system - pneumothorax - unstable angina - Recent myocardial infarction - Thrombosis in lower extremity - Acute myocarditis - Other diseases that will prevent exercise (infection, kidney failure)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
Individuals will not receive any interventions

Locations

Country Name City State
Turkey Öykünur CANSU Izmir

Sponsors (1)

Lead Sponsor Collaborator
Izmir Bakircay University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of Respiratory Functions Spirometry will be applied to evaluate respiratory functions.It is the most commonly performed lung function test, which evaluates volume against time using a device called a spirometer. The expiratory time should be at least 6 seconds and extended up to 15 seconds if necessary.The patient is instructed to take a deep breath and blow as hard and as fast as possible and take a deep breath to complete the flow volume cycle. The one with the highest values out of at least three tests done in succession is selected. at baseline
Primary Evaluation of Exercise Capacity 6 Minutes Walking Test will be applied to evaluate exercise capacity. The goal of this test is to walk the maximum distance that can be walked in 6 minutes. Average walking distances: 20/50 age:590-640m 60/70 age:540/570m 70/80 age:470-530m. at baseline
Primary Posture Assessment Posture assessment will be made using the New York Posture Rating Chart (NYPR).NYPR is an inexpensive, easy and fast-applied subjective postural assessment method that is widely used for clinical postural assessment. The grading chart is used to evaluate 13 areas of the body based on the assumption that posture is the alignment of the body and its parts.Each field is awarded a point based on position: 5 points for correct position; 3 points for a slight deviation and 1 point for a significant deviation. The total score ranges from 18-90 points. The higher the score, the better the postural alignment. at baseline
See also
  Status Clinical Trial Phase
Terminated NCT00932152 - Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer Phase 2
Completed NCT01740076 - Soy Nuts and Cardiovascular Risk in Postmenopausal Women N/A
Completed NCT03380000 - Effect of Beetroot Juice on Blood Pressure Regulation in Post Menopausal Women Phase 2
Recruiting NCT01259661 - Physical Activity and Metabolic Risk Factors in Postmenopausal Women N/A
Completed NCT00763464 - Coronary Artery Disease (CAD) in Postmenopausal Women N/A
Completed NCT00745108 - Tibolone Endometrium Study (Study 32972)(P06470) Phase 3
Completed NCT03644472 - Postmenopausal Women and Their Endothelium Phase 2
Terminated NCT05627791 - Effects of Vaginal Oxytocin Gel on Vaginal Cytologic Parameters in Postmenopausal Woman Phase 2/Phase 3
Recruiting NCT01472393 - Creatine on Bone Mass in Postmenopausal Women N/A
Recruiting NCT05964673 - Effect of Bioptron Light Therapy on Dryness of Eyes in Postmenopausal Women N/A
Completed NCT04762095 - The Effect of Mindfulness Stress Reduction Program on Menopausal Complaints and Quality of Life N/A
Recruiting NCT01376934 - Clinical Trial of Hysteroscopy in Postmenopausal Women to Compare Techniques N/A
Recruiting NCT03705845 - Tocotrienols for Obesity of Postmenopausal Women Phase 1/Phase 2
Completed NCT03940924 - HIIT + RT on Body Composition and Gut Microbiota in Postmenopausal Women (PACWOMan) N/A
Completed NCT00065546 - Human Requirements for the Nutrient Choline N/A
Completed NCT03191513 - The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Fat Metabolism N/A
Completed NCT03492983 - Effect of High Cocoa Content Chocolate on Health in Postmenopausal Women. N/A
Recruiting NCT06042673 - Impact of Pomegranate Seed Oil on Postprandial Cardiovascular Disease Risk Markers N/A
Completed NCT00577720 - Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate Phase 2
Completed NCT02094144 - Health Benefits of a 6-month Brisk Walking Program in Sedentary Postmenopausal Women N/A